A method for evaluation of activity of growth hormone-releasing hormone analogues.
It has been found that hGH-RH analogues with increased resistance to enzymatic degradation have a much higher potency than the native hGH-RH (1-29)-NH2 and have an ability to partially reverse growth hormone deficiencies. The aim of these studies was to elaborate a method which can be used for preliminary evaluation of new GH-RH analogues both from the point of view of their potency to release GH and enzymatic stability. Two highly active GH-RH analogues with increased resistance to trypsin-like enzymes, and hGH-RH(1-29)-NH2 used as a standard, in doses 1 nM, 10 nM, and 100 nM were added to pituitary rat cell culture, and medium was collected after 30, 60, 120 and 240 min. GH concentration was measured by RIA kit. It was observed that the potency of these two GH-RH analogues was several times higher than that of native compound. Moreover, the stimulation was much longer. This suggests that high activity of these analogues in vivo could be the result of increased enzymatic stability. This method can be used for selecting more potent and more stable releasing peptides before in vivo evaluation.